Artificial intelligence electrocardiogram as a novel screening tool to detect and longitudinally monitor high-risk echocardiographic features in hypertrophic cardiomyopathy
Quantitative Imaging in Medicine and Surgery · 2025-04 · 15 (4) · 2905-2916
DOI: 10.21037/qims-24-1638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Quantitative Imaging in Medicine and Surgery, 2025-04. Verfasst von Hongxia Ning und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Ultrasound, the First Hospital of China Medical University, Shenyang, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Current practice protocols for hypertrophic cardiomyopathy (HCM) recommend integrating crucial high-risk echocardiographic features associated with adverse prognosis into patient management. However, echocardiography is resource-limited and few powerful screening tools are available for risk assessment in the community. We aimed to devise an artificial intelligence (AI)-electrocardiogram (ECG) to identify high-risk echocardiographic features and monitor feature changes during long-term follow-up.
Methods
Patients with HCM from two hospitals who underwent both ECG and echocardiography within a 14-day window were retrospectively identified. One site (n=2,591) was used for training, validation and testing, and the other site (n=171) was used for external validation. An AI-ECG model was trained to predict the presence of any of the following four high-risk echocardiographic features: resting left ventricular outflow tract obstruction (LVOTO), massive left ventricular hypertrophy (LVH), systolic dysfunction, and apical aneurysm.
Results
The AI-ECG model exhibited an area under the receiver operating characteristic curve (AUROC) of 0.81 [95% confidence interval (CI): 0.76-0.86] and 0.80 (95% CI: 0.72-0.87) in the testing and external validation set for identifying high-risk features. During a median follow-up of 37 months (interquartile range, 30-53 months), in the testing set, 30 patients with no high-risk features at baseline were evaluated. Ten patients developed new high-risk features, and changes in the predicted probability score was well matched to the trend of changes in risk status. Patients with false-positive results at baseline had a threefold increased risk of developing high-risk features compared with the true-negatives [hazard ratio (HR) 3.36, 95% CI: 0.77-14.65; P=0.037].
Conclusions
The AI-ECG model effectively identified and longitudinally monitored high-risk echocardiographic features and may serve as a powerful community screening tool.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Ultrasound, the First Hospital of China Medical University, Shenyang, China.
- Clinical Medical Research Center of Imaging in Liaoning Province, Shenyang, China.
- Computer Science and Engineering, Northeastern University, Shenyang, China.
- Key Laboratory of Intelligent Computing in Medical Image, Ministry of Education, Northeastern University, Shenyang, China.
- National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Shenyang, China.
- Department of Ultrasound Diagnosis, Dalian Municipal Friendship Hospital, Dalian, China.
Zitieren
APA
Ning, H., Yu, Q., Kong, F., Li, G., Wang, Y., Zhang, B., Feng, Y., & Ma, C. (2025). Artificial intelligence electrocardiogram as a novel screening tool to detect and longitudinally monitor high-risk echocardiographic features in hypertrophic cardiomyopathy. Quantitative Imaging in Medicine and Surgery, 15(4), 2905-2916. https://doi.org/10.21037/qims-24-1638
Vancouver
Ning H, Yu Q, Kong F, Li G, Wang Y, Zhang B, et al. Artificial intelligence electrocardiogram as a novel screening tool to detect and longitudinally monitor high-risk echocardiographic features in hypertrophic cardiomyopathy. Quantitative Imaging in Medicine and Surgery. 2025;15(4):2905-2916. doi:10.21037/qims-24-1638
BibTeX
@article{Ning2025,
author = {Ning, Hongxia and Yu, Qi and Kong, Fanxin and Li, Guangyuan and Wang, Yonghuai and Zhang, Bo and Feng, Yong and Ma, Chunyan},
title = {Artificial intelligence electrocardiogram as a novel screening tool to detect and longitudinally monitor high-risk echocardiographic features in hypertrophic cardiomyopathy},
journal = {Quantitative Imaging in Medicine and Surgery},
year = {2025},
volume = {15},
number = {4},
pages = {2905--2916},
doi = {10.21037/qims-24-1638}
}
EUVIMED